RNA-protein interaction atlas of SARS-CoV-2 in infected human cells

HIRI scientist Mathias Munschauer, together with colleagues of the JMU Würzburg and the Broad Institute (Cambridge, USA), develops the first global atlas of direct interactions between the SARS-CoV-2 RNA and the proteome of the human host. The study was published as a preprint on bioRxiv.

SARS-CoV-2 infections pose a global threat to human health and an unprecedented research challenge. Among the most urgent tasks is obtaining a detailed understanding of the molecular interactions that facilitate viral replication or contribute to host defense mechanisms in infected cells.

While SARS-CoV-2 co-opts cellular factors for viral translation and genome replication, a comprehensive map of the host cell proteome in direct contact with viral RNA has not been elucidated.

Now, HIRI scientist Mathias Munschauer and colleagues established an unbiased and quantitative picture of the human proteome that directly binds the SARS-CoV-2 RNA in infected human cells.

The SARS-CoV-2 RNA interactome provides an unprecedented molecular perspective on SARS-CoV-2 infections and enables the systematic dissection of host dependency factors and host defense strategies, a crucial prerequisite for designing novel therapeutic strategies.

Browse the interactive RNA-proteome network in the online resource

To the online resource


A direct RNA-protein interaction atlas of the SARS-CoV-2 RNA in infected human cells
Nora Schmidt, Caleb A Lareau, Hasmik Keshishian, Randy Melanson, Matthias Zimmer, Luisa Kirschner, Jens Ade, Simone Werner, Neva Caliskan, Eric S Lander, Joerg Vogel, Steven A Carr, Jochen Bodem, Mathias Munschauer DOI: 10.1101/2020.07.15.204404

To the article

Nina-Vanessa Panitz

Press contact

Dr Nina-Vanessa Panitz

Nina is a trained parasitologist from the Karlsruhe Institute of Technology (KIT). As scientific coordinator at HIRI, she takes care of various activities at the interface of science and administration. She ensures that HIRI researchers can spend their time doing what they love: research.

This website uses cookies to enhance your user experience. By continuing to browse this website, you are agreeing to our use of cookies. More information